Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers
19 mars 2018 07h50 HE
|
Cannabis Science, Inc.
IRVINE, CA, March 19, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis...
Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis Beer
14 mars 2018 14h00 HE
|
Cannabis Science, Inc.
IRVINE, CA, March 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis...
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals
05 mars 2018 09h23 HE
|
Cannabis Science, Inc.
Grand Opening of First CBIS Pharmacies Expected Soon IRVINE, CA, March 05, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of...
Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social Media Educational Website
27 févr. 2018 07h42 HE
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the beta...
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options
22 févr. 2018 07h39 HE
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the...
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
02 févr. 2018 15h07 HE
|
Cannabis Science, Inc.
IRVINE, CA , Feb. 02, 2018 (GLOBE NEWSWIRE) --
Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, has entered into an expanded...
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
31 janv. 2018 14h28 HE
|
Cannabis Science, Inc.
IRVINE, CA , Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company’s...
Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings
29 janv. 2018 13h37 HE
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that...
Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals
18 janv. 2018 08h23 HE
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to report very strong...
Cannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.
10 janv. 2018 13h08 HE
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has...